Company / Depreciation & Amortization
Neogen Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$88.4M
FY2025
5-year range
$17.6M / $119.5M
FY2021-FY2025
Trend
-26.0%
vs FY2024
Sector context
#68 of 141
Health Care
What the data says
At $88M, Neogen's depreciation & amortization ranks #74 of 141 in the Health Care sector. Improved from $117M to $88M over the past 2 years.
Based on SEC 10-K filings.
$88M in FY2025 with a 5-year CAGR of +39.0%.
Improved from $117M to $88M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +68.7%
- 5-Year CAGR
- +39.0%
- 10-Year CAGR
- -
Sector benchmark
#74 of 141 in Health CareTop 52% of 141This company $88.4M Sector average $344.6M
▼
-74.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +39.0%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 26.0% year-over-year.
- Ranks #68 out of 141 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $88.4M | -26.0% |
| FY2024 | $119.5M | +2.4% |
| FY2023 | $116.7M | +534.5% |
| FY2022 | $18.4M | +4.4% |
| FY2021 | $17.6M | +3.3% |
| FY2020 | $17.1M | +16.1% |
| FY2019 | $14.7M | +20.6% |
| FY2018 | $12.2M | +14.4% |
| FY2017 | $10.6M | +16.0% |
| FY2016 | $9.2M | +23.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026